Acquisition Synergy Accriva Diagnostics is now part of Instrumentation Laboratory, presenting an opportunity to cross-sell and unify product portfolios such as coagulation, platelet aggregation, CO-Oximetry, and incision devices across IL’s global sales channels.

POC Expansion With Accriva’s strength in point-of-care coagulation testing and IL’s broader IVD ecosystem, target hospitals and clinics seeking integrated POCT solutions that streamline workflows and reduce turnaround times.

Remote & Connected Leverage IL’s ProDx remote support and GEMweb Plus connectivity capabilities to upsell networked analyzers and remote monitoring services to large hospital networks seeking IT-enabled quality management and uptime.

Growth Markets The combined entity can pursue mid to high-volume laboratories and clinical networks, expanding into new regions where IL has presence while leveraging Accriva’s CO-Oximetry and coagulation portfolios for diversification.

Financial Fit Revenue in the lower tens of millions and a mid-size employee base indicate a nimble, scalable add-on to IL’s enterprise solutions, presenting a compelling case for bundled offerings and long-term service contracts.